Culture

HIJ-PROPER trial -- Intensive cholesterol-lowering treatment: No significantly better outcomes

Rome, Italy - 29 August 2016: Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients with acute coronary syndrome (ACS) and dyslipidemia, investigators reported here.

AMERICA: No benefit to detecting and treating extra-coronary lesions

Rome, Italy - 29 August, 2016 : In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

CE-MARC 2: Pointing the way to fewer invasive angiograms

Rome, Italy - 29 August, 2016: Initial investigation of patients with suspected coronary heart disease (CHD) using functional imaging - rather than guideline-directed care - resulted in significantly less unnecessary angiography, according to results of the CE-MARC 2 trial.

OPTICARE trial enhanced cardiac rehab programs help heart attack patients

Rome, Italy - 29 Aug.2016: Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack.

The CONSERVE trial: Noninvasive imaging can guide more selective invasive coronary angiography

Rome, Italy 29 August 2016 - In stable symptomatic patients with suspected coronary artery disease, a strategy of using non-invasive computed tomography (CT) to guide the selective use of invasive coronary angiography was safe, and less expensive compared with direct invasive angiography.

DOCTORS trial: Invasive imaging sheds more light on percutaneous coronary intervention

Rome, Italy - 29 August 2016: An invasive imaging technique called optical coherence tomography (OCT) can visualize the coronary arteries in patients undergoing percutaneous coronary intervention (PCI) and lead to better outcomes compared to standard angiography-guided PCI, according to new findings reported here.

Results of the DOCTORS (Does Optical Coherence Tomography Optimize Results of Stenting) study were presented in a Hot Line session at ESC Congress 2016, with simultaneous publication in Circulation.

PACIFIC TRIAL: First head-to-head comparison of noninvasive coronary artery imaging

Rome, Italy - 29 August, 2016: For patients presenting for the first time with suspected coronary artery disease (CAD) clinicians have had a number of non-invasive diagnostic tests to choose from, but little evidence for which is best.

Now, findings from the PACIFIC trial may offer some guidance.

Calm or fiery? Study says candidate language should match the times

COLUMBUS, Ohio - Potential voters who see the nation as being in dire economic straits view a presidential candidate as more "presidential" when he or she uses high-intensity, emotional language, a new study suggests.

But people who think the country is doing just fine think a candidate sounds more presidential when the language is more restrained.

New UMN study: America's wars take uneven toll

In today's wars, Americans who die or are wounded in battle are disproportionately coming from poorer parts of the country, according to a new study released this week.

By analyzing over 500,000 American combat casualties from World War II through Iraq and Afghanistan, University of Minnesota Law Professor Francis Shen and Boston University Political Scientist Douglas Kriner found growing socioeconomic inequality in military sacrifice.

Heart failure in the elderly set to triple by 2060

Rome, Italy - 28 Aug 2016: Heart failure in the elderly is set to triple by 2060, according to new data from the Age, Gene/Environment Susceptibility (AGES) - Reykjavík study presented at ESC Congress 2016 today.1

Up to 80 percent of heart failure patients denied therapy to reduce hospitalization and death

Rome, Italy - 28 Aug 2016: A study in nearly 15 000 heart failure patients has found that up to 80% may not be receiving treatment at doses proven to reduce hospitalisations and improve survival. The research presented at ESC Congress 2016 today highlights the need for doctors to ensure patients are treated appropriately so that the high levels of serious illnesses and death associated with heart failure can be reduced.1

Increased risk of death for heart failure patients with each NHS hospital admission

Rome, Italy - 28 Aug 2016: Heart failure patients have a 2% increased risk of dying with each admission to NHS hospitals, according to research presented at ESC Congress 2016 today.1 The 15 year study in more than 450 000 patients from the ACALM Study Unit, Birmingham, UK included 13 416 patients with heart failure.

Nebivolol prevents anthracycline-induced cardiotoxicity

Rome, Italy - 28 Aug 2016: Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.1

"Breast cancer is a major public health problem worldwide, with a death rate of about 1 in 33 patients," said Professor Tomescu. "Anthracyclines are a class of powerful pharmacological agents widely used in the treatment of breast cancer but they have a toxic effect on the heart, inducing heart failure."

Mediterranean diet associated with lower risk of death in cardiovascular disease patients

Rome, Italy - 28 Aug 2016: The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.1

Sudden death in hypertrophic cardiomyopathy rarely associated with exercise

Rome, Italy - 28 Aug 2016: Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr Gherardo Finocchiaro, a cardiologist at St George's University of London, UK.1 Nearly 80% of patients in the study had no symptoms and only one in five had been diagnosed with HCM before their death.